Safer anesthesia for kids? study hunts for ideal ciprofol dose

NCT ID NCT07697404

Recruiting now Knowledge-focused Sponsor: Huazhong University of Science and Technology Source: ClinicalTrials.gov ↗

First seen Jul 13, 2026 · Last updated Jul 14, 2026 · Updated 1 time

Summary

This study aims to find the best dose of ciprofol, a new anesthetic similar to propofol but with fewer side effects, for placing a laryngeal mask airway (a type of breathing tube) in children aged 1 to 12. Children undergoing short surgeries will receive ciprofol along with a standard dose of fentanyl. The goal is to determine the dose that works 95% of the time, minimizing movement, coughing, or gagging during tube insertion.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: ciprofol
What this could lead to: If successful, this could establish a safer, more comfortable anesthesia method for children undergoing short surgeries.
What could go wrong: This is a small, early-phase dose-finding study, not a large trial. The results may not apply to all children or surgeries, and side effects like low blood pressure or breathing problems are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANESTHESIA INDUCTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

channelopathy-associated congenital insensitivity to pain, autosomal recessive

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANESTHESIA INDUCTION CIPROFOL LARYNGEAL MASK AIRWAY PEDIATRIC

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Tongji Hospital
RECRUITING

Wuhan, Hubei, 430030, China

Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.